KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Equity Average (2018 - 2025)

ClearPoint Neuro's Equity Average history spans 12 years, with the latest figure at $17.8 million for Q3 2025.

  • For Q3 2025, Equity Average fell 41.74% year-over-year to $17.8 million; the TTM value through Sep 2025 reached $17.8 million, down 41.74%, while the annual FY2024 figure was $23.3 million, 19.8% down from the prior year.
  • Equity Average for Q3 2025 was $17.8 million at ClearPoint Neuro, down from $19.9 million in the prior quarter.
  • Across five years, Equity Average topped out at $47.3 million in Q1 2022 and bottomed at $17.8 million in Q3 2025.
  • The 5-year median for Equity Average is $30.6 million (2024), against an average of $32.9 million.
  • The largest annual shift saw Equity Average soared 6088.58% in 2021 before it plummeted 41.74% in 2025.
  • A 5-year view of Equity Average shows it stood at $46.5 million in 2021, then fell by 17.37% to $38.4 million in 2022, then plummeted by 41.03% to $22.6 million in 2023, then increased by 20.15% to $27.2 million in 2024, then tumbled by 34.52% to $17.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Equity Average are $17.8 million (Q3 2025), $19.9 million (Q2 2025), and $22.7 million (Q1 2025).